CSL 90.49 Carlisle Companies Inc $CSL Hit a 52 week high of

New Post Public Reply Private Reply Replies (0) Message Board
DennyT
CSL 90.49 Carlisle Companies Inc $CSL Hit a 52 week high of 90.41 Closing the day 09:43 at 90.49 +0.33 +0.37% With a day low of 89.93 and a total volume of 7,284.

CSL Recent Posts: http://investorshangout.com/Carlisle-Companies-CSL-50634/

CSL Carlisle Companies Inc Recent Headline News

Pratt & Whitney Support Services for Chinese Airline - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Wed Nov 12, 5:30PM CST
Pratt & Whitney, one of the operating segments of diversified business conglomerate United Technologies Corp. (UTX), recently signed a long-term auxiliary power unit (APU) maintenance support deal with Zhejiang Loong Airlines.
FSS: 15.69 (-0.13), UTX: 108.79 (+0.65), CSL: 89.98 (-0.18), CLC: 67.01 (-0.24)

Honeywell to Upgrade Controls at 2 Turkish Refineries - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Tue Nov 11, 6:05PM CST
Honeywell Process Solutions, a part of Honeywell International Inc (HON), recently decided to upgrade controls at two refineries run by Tupras.
HON: 97.69 (+0.68), FSS: 15.69 (-0.13), CSL: 89.98 (-0.18), CLC: 67.01 (-0.24)

Carlisle Companies to Present at Baird's Industrial Conference in Chicago November 11
Business Wire - Tue Nov 11, 4:59AM CST
David A. Roberts, Chairman, President and CEO of Carlisle Companies Incorporated (NYSE:CSL), will be presenting at the Baird 2014 Industrial Conference at the Four Seasons Hotel at 120 Delaware Place in Chicago, IL, today, November 11, at 1:30 p.m. (Central). PowerPoint slides of the presentation are available on the Investor Relations section of Carlisle's website at www.carlisle.com.
CSL: 89.98 (-0.18)

Leucadia (LUK) Q3 Earnings Improve Y/Y on Solid Revenues - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Mon Nov 10, 10:30AM CST
Leucadia National Corporation (LUK) reported impressive results for third-quarter 2014. Earnings from continuing operations came in at $52.7 million or 14 cents per share.
LUK: 24.30 (-0.15), FSS: 15.69 (-0.13), CSL: 89.98 (-0.18), CLC: 67.01 (-0.24)

Carlisle Cos Earnings In Retrospect: Up 3.5% in the Last 20 Days (CSL)
Comtex SmarTrend(R) - Mon Nov 10, 9:17AM CST
20 days ago, on October 21st, 2014, Carlisle Cos (NYSE:CSL) reported its earnings. Analysts, on average, expected earnings of $1.22 per share on sales of $870.3 million. Carlisle Cos actually reported earnings of $1.31 per share on sales of $904.1 million, beating EPS estimates by $0.09 and beating revenue estimates by $33.9 million. Since the company's report, shares of Carlisle Cos have risen from $85.77 to $88.75, representing a gain of 3.5% in the past 20 days.
CSL: 89.98 (-0.18)

United Technologies Wins Contract Worth $22M - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Thu Nov 06, 5:22PM CST
UTC Aerospace Systems, a division of United Technologies Corp. (UTX), recently secured a contract worth $22 million from the U.S. Air Force for the supply of upgraded wheels and brakes for their F-15 series 475 aircraft.
UTX: 108.79 (+0.65), CSL: 89.98 (-0.18), CLC: 67.01 (-0.24)

Federal Signal (FSS) in Focus: Stock Moves 9.3% Higher - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Thu Nov 06, 7:30AM CST
Federal Signal Corp. (FSS) was a big mover last session, as the company saw its shares rise over 9% on the day.
CODI: 17.11 (-0.06), FSS: 15.69 (-0.13), CSL: 89.98 (-0.18), CLC: 67.01 (-0.24)

Carlisle Companies declares $0.25 dividend
Seeking Alpha - at Seeking Alpha - Wed Nov 05, 8:10AM CST

CSL: 89.98 (-0.18)

Carlisle Companies Declares Regular Quarterly Dividend
Business Wire - Wed Nov 05, 8:03AM CST
The Board of Directors of Carlisle Companies Incorporated (NYSE:CSL) has declared a regular quarterly dividend of $0.25 per share, payable on December 1, 2014 to shareholders of record at the close of business on November 19, 2014.
CSL: 89.98 (-0.18)

Is Leucadia National (LUK) Poised for Solid Results in Q3? - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Tue Nov 04, 5:25PM CST
Leucadia National Corporation (LUK) is scheduled to release third-quarter 2014 results on Nov 6.
LUK: 24.30 (-0.15), CSL: 89.98 (-0.18), CLC: 67.01 (-0.24)

Pitney Bowes Beats on Q3 Earnings, FY14 Guidance Raised - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Thu Oct 30, 1:06PM CDT
Profits during the quarter were driven by strength in the Digital Commerce Solution and mailing businesses.
CAJ: 31.15 (+0.24), PBI: 24.87 (+0.23), CSL: 89.98 (-0.18), CLC: 67.01 (-0.24)

Insider Trading Alert - CSL, GPI And SWHC Traded By Insiders
at The Street - Wed Oct 29, 9:15AM CDT
Stocks with insider trader activity include CSL, GPI and SWHC
GPI: 88.24 (-0.14), CSL: 89.98 (-0.18), SWHC: 9.70 (-0.12)

Trading Statement, Upcoming Earnings Release, Quarterly Earnings, and CSR Initiative - Research Reports on Unilever, SodaStream, Carlisle Companies, PVH and Lear
PR Newswire - Wed Oct 29, 8:05AM CDT
Today, Analysts Review released its research reports regarding Unilever plc (NYSE: UL), SodaStream International Ltd. (NASDAQ: SODA), Carlisle Companies Incorporated (NYSE: CSL), PVH Corp. (NYSE: PVH) and Lear Corp. (NYSE: LEA). Private wealth members receive these notes ahead of publication. To reserve complementary membership, limited openings are available at: http://www.analystsreview.com/7526-100free.
CSL: 89.98 (-0.18), UL: 40.90 (+0.50), SODA: 22.36 (+0.84), LEA: 93.39 (+0.96), PVH: 118.76 (-0.32)

Crane (CR) Misses Q3 Earnings on Low Core Sales Growth - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Tue Oct 28, 1:00PM CDT
Crane Co. (CR) reported its third-quarter 2014 earnings after the market closed on Oct 27.
CODI: 17.11 (-0.06), CR: 61.23 (-0.16), CSL: 89.98 (-0.18), CLC: 67.01 (-0.24)

Parker-Hannifin Q1 Earnings Beat Estimates, UP Y/Y - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Tue Oct 28, 12:55PM CDT
For the fiscal first quarter, the company reported adjusted earnings per share of $1.89, well above the Zacks Consensus Estimate of $1.66.
CODI: 17.11 (-0.06), PH: 128.66 (+0.09), CSL: 89.98 (-0.18), CLC: 67.01 (-0.24)

Novartis selling flu vaccine unit to CSL for $275M
AP - Mon Oct 27, 11:05AM CDT
NEW YORK (AP) — Australian drugmaker CSL Ltd. said Monday it will buy Novartis' flu vaccine business for $275 million.
CSL: 89.98 (-0.18), NVS: 94.40 (+1.74)

EMCOR Group's board elects John W Altmeyer as director
M2 - Mon Oct 27, 7:57AM CDT
The board of directors of EMCOR Group Inc (NYSE:EME), a provider of electrical and mechanical construction and facilities services, elected John W Altmeyer to it as director, expanding the board to 10 members, the company announced on Friday.
BHLB: 25.70 (-0.12), CSL: 89.98 (-0.18), EME: 45.31 (-0.27)

CSL to acquire Novartis' influenza vaccine business
PR Newswire - Mon Oct 27, 7:20AM CDT
CSL Limited (ASX:CSL; USOTC:CSLLY) today announced that it has agreed to acquire Novartis' global influenza vaccine business for US$275 million. The business will be combined with CSL's subsidiary, bioCSL.
CSL: 89.98 (-0.18)

5 Stocks Spiking on Unusual Volume
at The Street - Mon Oct 27, 6:00AM CDT
Keep these stocks trading on unusual volume on your trading radar.
SUSP: 46.00 (+0.69), LJPC: 11.84 (-1.30), IPCM: 38.72 (-0.09), EGBN: 35.63 (-0.31), CSL: 89.98 (-0.18)

Zacks Rank #1 Additions for Friday - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Fri Oct 24, 8:30AM CDT
Here are 5 stocks added to the Zacks Rank #1 (Strong Buy) List for Friday
CSL: 89.98 (-0.18), BIOD: 1.65 (+0.03), AWH: 37.64 (+0.36), TAST: 7.86 (+0.08), BCLI: 3.61 (+0.03)
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Regeneron Faces Legal Heat: Lead Plaintiff Deadline Looms

Updated Category News Views 3

Regeneron’s Tight Spot: Legal Showdown Well, here we go again—Regeneron Pharmaceuticals (NASDAQ:REGN) is under some serious heat. If you're an investor who faced significant losses with this biotech juggernaut, remember that the clock’s ticking down to the wire. By tomorrow, September 14, 2026, you need to decide if you're going to throw your hat in the ring for...

Continue Reading
PwC US and India Unite for Global Consultancy Powerhouse

Updated Category News Views 6

Rearranging the Consultancy Chessboard Piling onto the game of consultancy realignments, PwC just made a move reminiscent of playing strategy poker. They're tossing together PwC US and PwC India's advisory capabilities for a new joint venture. It’s like pushing two puzzle pieces to make a single colorful picture that stretches from the U.S. all the way to the...

Continue Reading
Tam-Peli Steps Up in SCLC Battle: Trial Insights

Updated Category News Views 5

Noteworthy Developments in Small-Cell Lung Cancer Treatment Let's dive into a story straight from the world of small-cell lung cancer (SCLC) that doesn't take any prisoners. The antidote making waves is tambotatug pelitecan, or Tam-Peli for short, showcasing its might in the unrelenting fight against relapsed SCLC. The phase III TAISHAN-302 trial puts Tam-Peli...

Continue Reading
First-Time Homeowners: Unseen Pitfalls of Insurance

Updated Category News Views 3

Understanding Homeowners Insurance: Beyond the Basics Most folks diving into homeownership for the first time get caught up in the whirlwind of price tags, loans, and knick-knacks for their new place. Meanwhile, the nitty-gritty of homeowners insurance often gets tossed to the side. But take it from a weary watchdog of financial storms—it’s those details in the policy...

Continue Reading
PANDAG G1 Debuts: Revolutionizing Lawn Care Efficiency

Updated Category News Views 4

The Future of Landscaping Unveiled Get this—PANDAG is set to shake things up at GaLaBau 2026 with their futuristic G1 autonomous mower. This isn't just another piece of lawn equipment; it's practically a tech marvel on wheels, weaving together LiDAR, AI Vision, RTK, and 4G tech to make it the ultimate multitasker for the landscaping industry. We're talking obstacle...

Continue Reading
Surfing Dogs Ride Waves, Support Orphan Pets

Updated Category News Views 3

Waves, Paws, and Passion Who would've thought that dogs catching waves could also catch hearts and wallets? Well, that's exactly what's happening today at Del Mar Dog Beach with the 21st Annual Surf Dog Surf-A-Thon revving up the excitement. It's a sun-soaked day in Rancho Santa Fe, California, right in the thick of things at the longest-running dog surf competition. For...

Continue Reading
Trial Disappointment: No Significant Gains in NSCLC

Updated Category News Views 10

Dissecting the Nuances of the EVOKE-03/KEYNOTE-D46 Trial Every once in a while, we come across a trial that rattles cages in the research community. Today, it's the EVOKE-03/KEYNOTE-D46 trial, a collision of hope and hard-knock reality. This Phase 3 trial, which sought to explore the potential combo of sacituzumab govitecan (SG) and pembrolizumab on metastatic non-small...

Continue Reading
UWM Faces Class Action Deadline: Key Insights for Investors

Updated Category News Views 2

The High Stakes Reality for UWM Investors If there's one thing that's certain in this jittery world of investing, it's that losses have a way of waking you up. Right now, anyone tied up with UWM Holdings Corporation (NYSE: UWMC) shares needs to keep their wits about them; we're barreling toward an October 13, 2026 deadline for a class action lawsuit. The clock's ticking...

Continue Reading
Ris-Rez May Set New Standard in Relapsed SCLC

Updated Category News Views 6

The Game-Changing Results Innovation in pharmaceuticals sometimes feels like a waiting game, but when a fresh breakthrough like this rolls in, it lights up the whole landscape. Risvutatug rezetecan, or Ris-Rez for short, has shown promising potential in the fight against relapsed small-cell lung cancer (SCLC) that has progressed after platinum-based therapy. Survival...

Continue Reading
GORGIE Unleashes Berry Burst: Target's New Drink Star

Updated Category News Views 5

GORGIE Targets Taste Buds with Berry Burst Ever feel like you're missing out on that energy drink everyone seems to be raving about? Well, GORGIE's out there making some noise again, and this time it's got a new punchy player in the game: Berry Burst. It's not just another drink; it's shaking things up in the energy aisle with its exclusive launch at Target. Modern style...

Continue Reading

Top 5 Most Recently Viewed Articles

Microbot Medical Secures $13 Million in Recent Offering

Updated Category News Views 92

Microbot Medical Makes Strategic Move with $13 Million Offering Microbot Medical Inc. (NASDAQ: MBOT) has recently taken an important step to elevate its operations by entering into definitive agreements to sell 6,103,289 shares of its common stock at a price of $2.13 per share. This registered direct offering, priced at-the-market under Nasdaq rules, underscores the...

Continue Reading
Evolv Technologies Faces Class Action Lawsuit: Know Your Rights

Updated Category News Views 651

Understanding the Evolv Technologies Holdings Class Action Recent developments have raised significant concerns among shareholders of Evolv Technologies Holdings, Inc. (NASDAQ: EVLV). A class action lawsuit is currently in progress, prompting investors to scrutinize the implications of false statements made by the company. The allegations revolve around misleading...

Continue Reading
Rhino Rescue Unveils Innovative First Aid Kits for Adventurers

Updated Category News Views 117

Rhino Rescue Launches Innovative Products for Outdoor Safety Rhino Rescue has made a remarkable stride in enhancing outdoor safety with its new lineup of first aid kits targeted towards adventurers and everyday users alike. The release of the Rhino Rescue Mini First Aid Kit, along with home and camping-specific options, marks an exciting development in the company’s...

Continue Reading
RUSH's 2026 Tour: Celebrating Legacy and New Beginnings

Updated Category News Views 258

RUSH's 2026 Tour: A Celebration of Music and Legacy Geddy Lee and Alex Lifeson are set to celebrate over 50 years of RUSH's musical journey as they announce a special headline tour for 2026, named the Fifty Something Tour. This tour not only commemorates the incredible music and legacy of RUSH, but also pays tribute to their late drummer and lyricist Neil Peart, whose...

Continue Reading
BioSyent Inc. Announces Quarterly Dividend for Shareholders

Updated Category News Views 132

BioSyent Inc. Announces Quarterly Dividend for Shareholders MISSISSAUGA, Ontario — BioSyent Inc. (TSX Venture: RX) is thrilled to communicate that its Board of Directors has approved a quarterly dividend of $0.05 per common share. This dividend will be paid in Canadian Dollars on a specified date to shareholders who are on record, enhancing the company's ongoing...

Continue Reading